MedPath

To study the effect of Swarnaprashan in reducing the frequency of illness in children by improving the immunity and increasing the body strength.

Phase 2
Completed
Conditions
Health Condition 1: D839- Common variable immunodeficiency,unspecified
Registration Number
CTRI/2021/05/033713
Lead Sponsor
ational Institute of Ayurveda Jaipur Rajasthan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

1. Children aged from 2-5 years of either sex

2. Childern with recurrent respiratory infections

3. Childern with recurrent G.I.T. diseases

4. Children with recurrent fever

5. Children with recuurent episodes of diarrhea

6. Children with other recurrent diseases

Exclusion Criteria

1. Subjects suffering from major systemic illness necessitating long term treatment

2. Subjects with evidence of malignancy

3. Subject with aspartate amino transferase(AST) and or alanine amino transferase ALT >3 Times of the upper normal limit and renal dysfunction (Sr. creatinine >1.2mg/dl), uncontrolled pulmonary dysfunction( asthmatic and COPD patients) .

4. Co-morbidity like TB, UTI and bleeding disorders etc

5. Congenital anomalies and hereditary disease.

6. Pulmonary or abdominal tuberculosis.

7. H/O hypersensitivity to any of the trial drug or any of its ingredients.

8. Subjects who have completed participation in any other clinical trial during the past six months.

9. Any contraindications mentioned for Lehan karma in Kashyap Samhita.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To Observe the Immunomodulatory effect of Swarnaprashan.Timepoint: 8 weeks
Secondary Outcome Measures
NameTimeMethod
Reduction in Morbidity rate in children.Timepoint: 8 weeks
© Copyright 2025. All Rights Reserved by MedPath